Month: March 2025

Scalable and flexible solutions to design diverse models of e-scooters and e-bikes CHANDLER, Ariz., March 17, 2025 (GLOBE NEWSWIRE) — The electric two-wheeler market is transforming the transportation industry as consumers embrace e-scooters and e-bikes for both recreational use and daily commuting. Microchip Technology (Nasdaq: MCHP) today announces the launch of its Electric Two-Wheeler (E2W) ecosystem, a comprehensive suite of pre-validated reference designs that addresses key challenges in e-scooter and e-bike development, including power efficiency, system integration, safety and time-to-market. By offering automotive-grade, scalable solutions, Microchip enables manufacturers to streamline development and build reliable, feature-rich electric two-wheelers. Microchip’s automotive-grade components and modular reference designs...

NEW YORK, March 17, 2025 (GLOBE NEWSWIRE) — Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, today announced that the CEO of Tiziana Life Sciences, Ivor Elrifi, will be presenting during a fireside chat at the 37th Annual ROTH Conference and host 1×1 investor meetings. The Conference is being held March 16-18, 2025, in Dana Point, California. This year’s event will consist of 1-on-1 / small group meetings, analyst-selected fireside chats, industry keynotes and panels with executive management attending from approximately 450 private and public companies in a variety of growth sectors. Presentation Details:Date: Tuesday, March...

SHENZHEN, China, March 17, 2025 (GLOBE NEWSWIRE) — MicroCloud Hologram Inc. (NASDAQ: HOLO), (“HOLO” or the “Company”), a technology service provider, they are researching CV-QNN (Continuous Variable Quantum Neural Networks) technology, with the aim of building Variational Quantum Circuits embedded in CV architecture. In this way, it is possible not only to quantumize classical neural networks, but also to design various specialized quantum models, such as convolutional quantum networks, recursive quantum networks, and residual quantum networks, providing new tools for quantum artificial intelligence technology. The core of HOLO CV-QNN lies in achieving affine transformations and nonlinear mappings in neural networks through layered continuously parameterized quantum gates and nonlinear activation functions. The CV architecture...

Agreement extends Pipe17’s connectivity network to BigCommerce and Feedonomics customers to reach critical fulfillment endpoints AUSTIN, Texas, March 17, 2025 (GLOBE NEWSWIRE) — BigCommerce (Nasdaq: BIGC), a leading provider of open, composable commerce solutions for B2C and B2B brands, retailers, manufacturers and distributors today announced a transformational partnership with Pipe17, a leading provider of AI-powered composable order operations. This partnership reimagines how modern merchants manage orders in an increasingly complex digital commerce ecosystem. BigCommerce empowers brands, retailers, manufacturers and distributors of all sizes to sell online and capture orders seamlessly. Feedonomics, BigCommerce’s AI-powered product data feed management and order orchestration solution, helps brands list, manage and optimize...

Twin Hospitality Group Inc.Twin Peaks Opens New Lodge in Algonquin, Illinois, on March 17Ultimate sports lodge brings scratch-made food, 29-degree draft beer, and premium sports watching atmosphere to the Chicago area — just in time for St. Patrick’s Day Chicago, Ill., March 17, 2025 (GLOBE NEWSWIRE) — Twin Hospitality Group Inc. (Nasdaq: TWNP), the parent company of Twin Peaks Restaurant, is bringing the luck of the lodge to the Chicago area with its newest location in Algonquin, opening Monday, March 17, creating the perfect spot for St. Patrick’s Day celebrations. Known for its 29-degree draft beer, made-from-scratch kitchen and unbeatable game-day environment, this marks Twin Peaks’ fourth location in Illinois and the 116th lodge across the U.S. and Mexico. Located at 1520 South Randall Road in the Algonquin Commons,...

PHOENIX, March 17, 2025 (GLOBE NEWSWIRE) — WillScot Holdings Corporation (“WillScot” or the “Company”) (Nasdaq: WSC), a leader in innovative temporary space solutions, today announced it is amending the Consent Solicitations of its indirect subsidiary, Williams Scotsman, Inc. (“WSI”), soliciting consents (“Consents”) from holders of its existing 6.625% Senior Secured Notes due 2029 (the “2029 Notes”) and the holders of its 7.375% Senior Secured Notes due 2031 (the “2031 Notes” and, together with the 2029 Notes, the “Existing Notes”) as of the record date of March 11, 2025 (the “Record Date”) for the adoption of certain amendments (the “Proposed Amendments”) to the indentures governing the Existing Notes. The Consent Solicitations for each series of Existing Notes (collectively, the “Consent Solicitations” and, with respect to each...

-Reported positive 16-week results from the extension phase of the Phase 2b RewinD-LB trial of neflamapimod in dementia with Lewy bodies (DLB), including improvement on the trial’s primary outcome measure- -Plan to initiate Phase 3 trial in mid-2026 following meeting with regulatory authorities- -Awarded 2024 Prix Galien USA Award as “Best Startup” by the Galien Foundation- BOSTON, March 17, 2025 (GLOBE NEWSWIRE) —  CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders (CervoMed or the Company), today reported its financial results for the fourth quarter and full year ended December 31, 2024. “Following the highly encouraging 16-week extension results from our Phase 2b RewinD-LB trial, we believe we have established proof-of-concept for neflamapimod as a potential...

Antitumor activity observed with confirmed partial responses in 50% of patientsat highest dose tested to date, across multiple tumor types PLN-101095 was generally well tolerated across all doses SOUTH SAN FRANCISCO, Calif., March 17, 2025 (GLOBE NEWSWIRE) — Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced data from the first three of five potential cohorts of its ongoing Phase 1 dose escalation clinical trial evaluating PLN-101095, an integrin αvβ8 and αvβ1 inhibitor, in combination with pembrolizumab, in patients with immune checkpoint inhibitor (ICI) -refractory advanced or metastatic solid tumors. Interim results demonstrated PLN-101095 anti-tumor activity in combination with pembrolizumab, with three partial responses observed in cohort three at the 1000 mg administered orally twice daily (BID) dose, representing a...

The US Government Granted Athena GTX a $2,866,000 Final Development Contract Award! JACKSON CENTER, Pa., March 17, 2025 (GLOBE NEWSWIRE) — Halberd Corporation (OTC: HALB) partnered with Athena GTX on a profit-sharing agreement over a year ago. This enabled Halberd to utilize Athena’s expertise and experience in dealing with the federal government. Of the two technologies associated with Traumatic Brain Injuries (TBI)/Suicide Ideation for which we chose to pursue government funding, Athena’s success via the WatchDawg® Pilot Study was chosen to lead the Suicide Ideation treatment project, while Halberd, via the successful Mississippi State University initial animal tests, leads the TBI mitigation nasal spray development program. The website we established to do the hard work on market development and FDA clearance for our LDX adjunct...

SALT LAKE CITY, Utah, March 17, 2025 (GLOBE NEWSWIRE) — Sintx Technologies, Inc. (NASDAQ: SINT) (“Sintx” or the “Company”), a leader in advanced ceramics for medical device and technical applications, today announced that Dr. Sonny Bal has retired as Chairman of the Board, and the Board of Directors has unanimously appointed Eric Olson, the Company’s Chief Executive Officer, as its new Chairman, effective immediately. Dr. Bal, who has served as Chairman since 2015, has played a crucial role in driving Sintx’s transformation, strengthening its core business, and positioning the Company for growth in the advanced materials sectors. He will continue to support the Company as a member of the Board of Directors, ensuring continuity as Sintx executes on its strategic objectives. “On behalf of the Board and the entire Sintx team, I want...